Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline

Infectious Agents and Cancer

Volumn 4, Issue 1, 2009, Pages

  Schiffman, Mark ^a   Clifford, Gary ^b   Buonaguro, Franco M ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

CANCER EPIDEMIOLOGY; CANCER SCREENING; CARCINOGENICITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; NONHUMAN; PHYLOGENY; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS; WORLD HEALTH ORGANIZATION;

EID: 67949094324     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-4-8     Document Type: Review

References (25)

1. Human papillomavirus and cervical cancer. M Schiffman PE Castle J Jeronimo AC Rodriguez S Wacholder, Lancet 2007 370 9590 890 907 10.1016/S0140-6736(07)61416-0 17826171
2. The Evolving Definition of Carcinogenic Human Papillomavirus Infectious. P Castle, Agents and Cancer 2009
3. A review of human carcinogens? Part B: biological agents. V Bouvard R Baan K Straif Y Grosse B Secretan F El Ghissassi L Benbrahim-Tallaa N Guha C Freeman L Galichet V Cogliano WHO International Agency for Research on Cancer Monograph Working Group, Lancet Oncol 2009 10 4 321 2 10.1016/S1470-2045(09) 70096-8 19350698
4. Human Papillomaviruses. IARC Monographs, IARC Monographs on the Evaluation of Carcinogenic Risks to Human IARC, Lyon, France 64
5. Carcinogenicity of human papillomaviruses. V Cogliano R Baan K Straif Y Grosse B Secretan F El Ghissassi WHO International Agency for Research on Cancer, Lancet Oncol 2005 6 4 204 10.1016/S1470-2045(05)70086-3 15830458
6. The carcinogenicity of human papillomavirus types reflects viral evolution. M Schiffman R Herrero R Desalle A Hildesheim S Wacholder AC Rodriguez MC Bratti ME Sherman J Morales D Guillen M Alfaro M Hutchinson TC Wright D Solomon Z Chen J Schussler PE Castle RD Burk, Virology 2005 337 1 76 84 10.1016/j.virol.2005.04.002 15914222
7. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. FX Bosch AN Burchell M Schiffman AR Giuliano S de Sanjose L Bruni G Tortolero-Luna SK Kjaer N Mũoz, Vaccine 2008 26 Suppl 10 K1 16 10.1016/j.vaccine.2008.05.064 18847553
8. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. JS Smith L Lindsay B Hoots J Keys S Franceschi R Winer GM Clifford, Int J Cancer 2007 121 3 621 32 10.1002/ijc.22527 17405118
9. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16, or 18, and the possible utility of type-specific HPV testing in clinical practice. MJ Khan PE Castle AT Lorincz S Wacholder M Sherman DR Scott BB Rush AG Glass M Schiffman, J Natl Cancer Inst 2005 97 14 1072 9 16030305
10. HPV screening for cervical cancer in rural India. R Sankaranarayanan BM Nene SS Shastri K Jayant R Muwonge AM Budukh S Hingmire SG Malvi R Thorat A Kothari R Chinoy R Kelkar S Kane S Desai VR Keskar R Rajeshwarkar N Panse KA Dinshaw, N Engl J Med 2009 360 14 1385 94 10.1056/NEJMoa0808516 19339719
11. From India to the world? a better way to prevent cervical cancer. M Schiffman S Wacholder, N Engl J Med 2009 360 14 1453 5 10.1056/NEJMe0901167 19339726
12. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. CM Wheeler WC Hunt M Schiffman PE Castle Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group, J Infect Dis 2006 194 9 1291 9 10.1086/507909 17041856
13. New technologies in cervical cancer screening. PE Gravitt F Coutlée T Iftner JW Sellors WG Quint CM Wheeler, Vaccine 2008 26 Suppl 10 K42 52 10.1016/j.vaccine.2008.05.002 18847556
14. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. GM Clifford JS Smith T Aguado S Franceschi, Br J Cancer 2003 89 1 101 5 10.1038/sj.bjc.6601024 12838308
15. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. S de Sanjosé M Diaz X Castellsagué G Clifford L Bruni N Mũoz FX Bosch, Lancet Infect Dis 2007 7 7 453 9 10.1016/S1473-3099(07)70158-5 17597569
16. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. GM Clifford RK Rana S Franceschi JS Smith G Gough JM Pimenta, Cancer Epidemiol Biomarkers Prev 2005 14 5 1157 64 10.1158/1055-9965.EPI-04-0812 15894666
17. Members of the human papillomavirus type 18, family (alpha-7 species) share a common association with adenocarcinoma of the cervix. G Clifford S Franceschi, Int J Cancer 2008 122 7 1684 5 10.1002/ijc.23282 18059025
18. Molecular diagnosis of human papillomavirus (HPV) infections. A Molijn B Kleter W Quint LJ van Doorn, J Clin Virol 2005 32 Suppl 1 S43 51 10.1016/j.jcv.2004.12.004 15753011
19. Human papillomavirus type 26, infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. A Handisurya A Rieger A Bankier A Koller A Salat G Stingl R Kirnbauer, Br J Dermatol 2007 157 4 788 94 Epub 2007, Jul 19. Erratum in: Br J Dermatol. 2007, Dec;157(6):1304. 10.1111/j.1365-2133.2007.08094.x 17634082
20. A study of the impact of adding HPV types to cervical cancer screening and triage tests. M Schiffman MJ Khan D Solomon R Herrero S Wacholder A Hildesheim AC Rodriguez MC Bratti CM Wheeler RD Burk PEG Group; ALTS Group, J Natl Cancer Inst 2005 97 2 147 50 15657345
21. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Z Gudleviciene J Didziapetriene M Ramael S Uleckiene KP Valuckas, Gynecol Oncol 2006 102 3 530 3 10.1016/j.ygyno.2006.01.019 16488468
22. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. N Wentzensen M Schiffman ST Dunn RE Zuna J Walker RA Allen R Zhang ME Sherman S Wacholder J Jeronimo MA Gold SS Wang, Int J Cancer 2009 124 4 964 9 10.1002/ijc.23969 19030188
23. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. F Gargiulo MA De Francesco C Schreiber G Ciravolo F Salinaro B Valloncini N Manca, Virus Res 2007 125 2 176 82 10.1016/j.virusres.2006.12.017 17257705
24. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. S Andersson M Mints J Sällström E Wilander, Cancer Detect Prev 2005 29 1 37 41 10.1016/j.cdp.2004.11.003 15734215
25. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. H De Vuyst P Gichangi B Estambale E Njuguna S Franceschi M Temmerman, Int J Cancer 2008 122 1 244 6 10.1002/ijc.23045 17764116